Nimotop Tablet 30mg

Nimotop Tablet 30mg contains the active ingredient nimodipine, which belongs to the class of medications known as calcium channel blockers. It is available in tablet form and is primarily used in the management of certain neurological conditions, particularly subarachnoid hemorrhage (bleeding in the space surrounding the brain).

Active Ingredient:

Nimodipine: Nimodipine acts by inhibiting the influx of calcium ions into vascular smooth muscle cells, resulting in vasodilation (widening of blood vessels). This mechanism helps to improve blood flow in the brain, which is crucial in conditions like subarachnoid hemorrhage.

Mechanism of Action:

Nimodipine selectively inhibits the calcium channels in cerebral blood vessels, leading to relaxation and dilation of these vessels. By improving cerebral blood flow, nimodipine helps to prevent and manage cerebral vasospasm, a potentially serious complication following subarachnoid hemorrhage.

Uses:

Nimotop Tablet 30mg is primarily indicated for:

• Prevention and treatment of cerebral vasospasm associated with subarachnoid hemorrhage.
• Management of certain neurological conditions characterized by impaired cerebral blood flow.

Dosage and Administration:

The dosage of Nimotop Tablet 30mg should be individualized based on the patient’s condition, response to treatment, and tolerance. Typically, the recommended dose is 60mg (two tablets) every 4 hours for 21 consecutive days via oral administration, starting within 96 hours of the onset of subarachnoid hemorrhage.

Side Effects:

Common side effects of Nimotop Tablet 30mg may include:

• Headache
• Dizziness
• Flushing
• Nausea
• Low blood pressure (hypotension)
• Gastrointestinal disturbances

Precautions:

• Nimotop Tablet 30mg should be used with caution in patients with hypotension, liver dysfunction, or renal impairment.
• Grapefruit juice should be avoided during nimodipine treatment as it may increase the risk of adverse effects.
• Nimodipine may interact with other medications, so it’s important to inform the healthcare provider about all current medications.
• Pregnant or breastfeeding women should consult their healthcare provider before using Nimotop Tablet 30mg.

Conclusion:

Nimotop Tablet 30mg, containing nimodipine, is a calcium channel blocker primarily used in the prevention and treatment of cerebral vasospasm following subarachnoid hemorrhage. Its vasodilatory effects help to improve cerebral blood flow and mitigate the risk of neurological complications associated with this condition.